Adults and Pediatric Patients Aged

FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults

The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.